Friday, October 15, 2021

University of Oxford links up with Evox Therapeutics

The University of Oxford’s Harrington Rare Disease Centre has entered a strategic collaboration agreement with Evox Therapeutics focused on rare diseases within the Department of Paediatrics.

Evox Therapeutics is an Oxford-based biotech company focused on exosomes – also known as extracellular vesicles.

The company’s DeliverEX technology is used to modify exosomes using various molecular engineering, drug loading and targeting strategies to enable targeted drug delivery to organs of interest – including the brain and the central nervous system.

The Oxford-Harrington Rare Disease Centre specialises in rare disease translational research. The collaboration between Evox and will support new approaches to identifying and developing exosome therapeutics for the treatment of rare diseases.

“We are very pleased to be collaborating with a world-class institute like the Oxford-Harrington Rare Disease Centre on exosomes and their application to the treatment of life-threatening rare diseases,” said Antonin de Fougerolles, chief executive officer of Evox.

“In bringing together our expertise, we can maximise the potential of our exciting technology to bring more options to patients struggling with rare diseases,” he added.

The collaboration will also enable the acceleration of translational exosome therapeutics research projects and aims to create a team of expert scientists with in-depth knowledge of the exosome drug discovery process.

“Exosome therapeutics have the potential to significantly alter the landscape of rare disease treatment for the better,” said Professor Georg Holländer, department head of Paediatrics, University of Oxford.

We are delighted to have entered into this collaboration with Evox, a leader in the field, to explore this area. We will look to leverage our joint resources and scientific expertise to identify exciting new treatment options,” he added.

Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...